SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $21,000 | -16.0% | 156 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $25,000 | +127.3% | 156 | +40.5% | 0.00% | +100.0% |
| Q1 2020 | $11,000 | -21.4% | 111 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $14,000 | +75.0% | 111 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $8,000 | -65.2% | 111 | -28.8% | 0.00% | -60.0% |
| Q2 2019 | $23,000 | +53.3% | 156 | +23.8% | 0.01% | +66.7% |
| Q1 2019 | $15,000 | -21.1% | 126 | -28.4% | 0.00% | -40.0% |
| Q4 2018 | $19,000 | -26.9% | 176 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $26,000 | -3.7% | 176 | -16.6% | 0.01% | 0.0% |
| Q2 2018 | $27,000 | – | 211 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |